Neil J Korman MD

PubMed

• Association Between Hurley Stage and Comorbidities in Hidradenitis Suppurativa.
  Jack Fite, Henry Herrera, Neil J Korman
  International Journal of Dermatology. 2026-05-01
• 1 citations
  The impact of GLP-1 receptor agonists on clinical outcomes and healthcare utilization in hidradenitis suppurativa patients: A retrospective cohort study using TriNetX.
  Jack Fite, Alison M Treichel, Thomas S McCormick, Neil Korman, Kevin D Cooper
  Journal of the American Academy of Dermatology. 2026-03-01
• 1 citations
  Patient Experiences of Bullous Pemphigoid: Symptoms and Health-Related Quality of Life Impacts.
  Calvin N Ho, Lila Bahadori, Marc Yale, Naomi Bishop, Caroline Roberts
  Dermatology and Therapy. 2025-07-01

Journal Articles

• Long-term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate-to-severe psoriasis: results from the PHOENIX 2 study throu...  
  Langley RG, Lebwohl M, Krueger GG, Szapary PO, Wasfi Y, Chan D, Hsu MC, You Y, Poulin Y, Korman NJ, Prinz JC, Reich K, Br J Dermatol, 1/1/2015
• Definitions and outcome measures for mucous membrane pemphigoid: recommendations of an international panel of experts  
  Murrell DF, Marinovic B, Caux F, Prost C, Ahmed R, Wozniak K, Amagai M, Bauer J, Beissert S, Borradori L, Culton D, Fairley JA, Fivenson D, Jonkman MF, Marinkovich MP,..., J Am Acad Dermatol, 1/1/2015
• Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate to severe plaque psoriasis: 52-week results of a phase 3, randomised, controlled trial (ES...  
  Papp K, Reich K, Leonardi CL, Kircik L, Chimenti S, Langley RGB, Hu CC, Stevens RM, Day RM, Gordon KB, Korman NJ, Griffiths CEM, J Am Acad Dermatol, 1/1/2015

Books/Book Chapters

• Blistering Diseases 
  Chapter: Pemphigus vulgaris. 
  Page 383 - 388Kim J, Hertl M, Korman NJ, Murrell DFEditors: Murrell DF.2015
• UpToDate 
  Chapter: Comorbid disease in psoriasis. 
  Korman NJEditors: Basow DS.UpToDate, Waltham, MA2011
• Challenging Cases in Allergic and Immunologic Diseases of the Skin 
  Chapter: Autoimmune Blistering Diseases of the Skin and Mucous Membranes. 
  Page 303 - 321Patton T, Korman NJEditors: Mahmoudi M.Springer, New York, NY2010

Abstracts/Posters

• Final Results of Phase 1/1b Study of Tenalisib, Dual PI3K _/_ Inhibitor in Patients with Relapsed/Refractory T-Cell Lymphoma
  Neil Korman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Myeloid biomarkers and vascular PET-MRI during psoriasis treatments: preliminary report.
  Golden JB, Santilli S, Muakkassa F, Prabhakar R, O'Donnell JK, Groft S, Galimberti F, Soler DC, McCormick TS, Korman NJ, Cooper KD, J Invest Dermatol, 1/1/2015
• Autosomal Dominant Transgradient Palmoplantar Keratoderma (PPK) and Hypotrichosis Treated Adequately with 13-Cis Retinoic Acid and Acitretin: a novel kindred and reass...
  Cohn HI, Korman NJ, J Invest Dermatol, 1/1/2015

Lectures

• Autoimmune Blistering Diseases: What's New 
  American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/1/2019
• Introduction to Clinical Dermatology 
  Case Western Reserve University School of Medicine - 1/1/2015
• Advanced Systemic Therapies 
  Colorado Springs, CO - 1/1/2015